Statements of Cash Flows - USD ($)	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (3,126,811)	$ (1,968,746)
Adjustments to reconcile net loss to net cash used in operating activities
Preferred shares issued as compensation	14,408	9,617
Common shares issued as compensation and for services	45,750	61,850
Warrants granted to Scientific Advisory Board	229	159
Depreciation	193,546	187,057
Amortization	2,067	2,067
Changes in operating assets and liabilities:
Prepaid expenses	(2,391)	122,204
Other assets	4,409	37
Accounts payable	336,594	72,147
Accounts payable - related parties	(83,489)	146,051
Accrued expenses	20,825	195,863
NET CASH USED IN OPERATING ACTIVITIES	(2,594,863)	(1,171,694)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment	(46,764)	(8,291)
NET CASH USED IN INVESTING ACTIVITIES	(46,764)	(8,291)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net proceeds from sale of common stock	1,710,138	0
NET CASH PROVIDED BY FINANCING ACTIVITIES	1,710,138	0
NET CHANGE IN CASH AND CASH EQUIVALENTS	(931,489)	(1,179,985)
Cash and cash equivalents at beginning of period	4,797,778	8,149,808
Cash and cash equivalents at end of period	3,866,289	6,969,823
NON CASH FINANCING AND INVESTING ACTIVITIES:
Related party non-current liability converted to note payable	0	1,500,000
Forgiveness of interest on related party debt	$ 0	$ 49,808